Zhang Xueyan, Zhou Lijuan, Peng Pingzhi, Zhang Weiquan, Liang Chunhong
Department of Pharmacy, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, 537000, People's Republic of China.
Office of Drug Clinical Trial Institution, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, 537000, People's Republic of China.
Infect Drug Resist. 2025 Mar 29;18:1647-1656. doi: 10.2147/IDR.S500379. eCollection 2025.
Despite the widespread adoption of antimicrobial stewardship (AMS) programs, their effectiveness varies because of differing regional policies and socioeconomic factors. This study aimed to assess the impact of AMS at a Chinese tertiary care hospital on inpatient antimicrobial use and bacterial resistance during the COVID-19 outbreak.
An interrupted time-series regression analysis was conducted to compare inpatient antimicrobial use between pre- and post-intervention periods. The Chi-squared test and linear regression analysis were used to compare bacterial resistance and illustrate temporal trends in bacterial resistance, respectively.
Following the AMS strategy implementation, we observed a significant decrease in antimicrobial consumption at unrestricted (β2 = -6.38, P = 0.004), restricted (β2 = -17.81, P < 0.001), and special levels (β2 = -2.32, P < 0.001). Despite a reduction in the use of third-generation cephalosporins and macrolides (β2 = -6.85, P < 0.001; β2 = -2.82, P < 0.001), an increase in the trend of use was observed post-intervention (β3 = 0.15, P < 0.001; β3 = 0.04, P = 0.001). Methicillin resistance in significantly decreased (β = -0.23, P < 0.001) from 52.85% to 40.92%. Conversely, the prevalence of carbapenem-resistant increased from 4.69% to 10.87% (P < 0.001), whereas resistance to and marginally decreased (P<0.05). We observed decreases in the antimicrobial utilization rate (β2 = -11.86, P = 0.003) and combination utilization rate (β2 = -12.36, P = 0.011) post-intervention. No significant changes in special-level antimicrobial and prophylactic agent use in category I incisional surgeries were observed.
An AMS program in a Chinese tertiary facilitated effective management of antimicrobial use and reduction of bacterial resistance during the COVID-19 pandemic, in the context of combined infection prevention and control measures. The findings provide useful insights for the implementation of antimicrobial stewardship in future public health crises.
尽管抗菌药物管理(AMS)计划已广泛采用,但其有效性因地区政策和社会经济因素的不同而有所差异。本研究旨在评估中国一家三级医疗机构的AMS计划在新冠疫情期间对住院患者抗菌药物使用及细菌耐药性的影响。
采用中断时间序列回归分析比较干预前后住院患者的抗菌药物使用情况。分别使用卡方检验和线性回归分析比较细菌耐药性并阐明细菌耐药性的时间趋势。
实施AMS策略后,我们观察到非限制级(β2 = -6.38,P = 0.004)、限制级(β2 = -17.81,P < 0.001)和特殊使用级(β2 = -2.32,P < 0.001)抗菌药物的消耗量均显著下降。尽管第三代头孢菌素和大环内酯类药物的使用量有所减少(β2 = -6.85,P < 0.001;β2 = -2.82,P < 0.001),但干预后使用趋势有所增加(β3 = 0.15,P < 0.001;β3 = 0.04,P = 0.001)。金黄色葡萄球菌的耐甲氧西林率从52.85%显著下降至40.92%(β = -0.23,P < 0.001)。相反,耐碳青霉烯类肺炎克雷伯菌的患病率从4.69%升至10.87%(P < 0.001),而对铜绿假单胞菌和鲍曼不动杆菌的耐药性略有下降(P<0.05)。我们观察到干预后抗菌药物使用率(β2 = -11.86,P = 0.003)和联合使用率(β2 = -12.36,P = 0.011)均有所下降。在I类切口手术中,特殊使用级抗菌药物和预防用抗菌药物的使用未观察到显著变化。
在中国一家三级医疗机构实施的AMS计划,在联合感染预防与控制措施的背景下,有助于在新冠疫情期间有效管理抗菌药物使用并降低细菌耐药性。这些研究结果为未来公共卫生危机中实施抗菌药物管理提供了有益的见解。